The complexity of the functions of STAT3 inGBM underscores its potential as a therapeutic target, with strategies aimed at inhibitingits pathways showing promise in curtailing the formidable self-renewal and tumorigenicityof GSCs, thereby offering a new avenue for overcoming therapeutic resistance in thisaggressive cancer. The gene discussed is STAT3; the disease is cancer.